JME

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Medical Ethics 2008;34:206-209; doi:10.1136/jme.2006.020016
Copyright © 2008 by the BMJ Publishing Group Ltd & Institute of Medical Ethics.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helgesson, G
Right arrow Articles by Swartling, U
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helgesson, G
Right arrow Articles by Swartling, U

Research ethics

Views on data use, confidentiality and consent in a predictive screening involving children

1 Unit for Bioethics at the Department of LIME, Karolinska Institutet and Uppsala University, Uppsala, Sweden
2 The ABIS Research Group, Division of Paediatrics and Diabetes Research Centre, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden

Correspondence to:
G Helgesson, Unit for Bioethics, Department of LIME, Karolinska Institutet, Berzelius väg 3, SE-171 77 Stockholm, Sweden; gert.helgesson{at}ki.se

Data from the 5–6 year control questionnaire of the ABIS study, a Swedish prospective screening of children for Type 1 diabetes, indicates a genuine trust in the researchers—very few participating families expressed concern about their participation. Nevertheless, a majority do not want their research data to be used beyond the agreement of the original consent. They want to be asked for renewed consent in such cases. A vast majority also want potential high-risk information about their child to be communicated to them. Most participating families want this regardless of whether any preventive treatment is available. Although potential benefits for their child is a motivation for participation for a majority of the respondents, they also claim to be motivated by altruistic reasons. These results are compared to results from two similar studies in the UK.


Keywords: Children; concern; high-risk information; informed consent; longitudinal studies




This article has been cited by other articles:


Home page
Clin EthicsHome page
U. Swartling, G. Helgesson, M. G Hansson, and J. Ludvigsson
Parental authority, research interests and children's right to decide in medical research - an uneasy tension?
Clin Ethics, June 1, 2008; 3(2): 69 - 74.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd & Institute of Medical Ethics.